Thank you to everyone who spent time with us at ASMS 2026!
UniDirect HT-MS generated more conversations than we anticipated, and we’re ready to keep them going.
Here’s what people are excited about:
UniDirect is a high-throughput ESI-MS platform that removes LC from the equation entirely. Built on breakthrough multispray technology, it combines autosampling, the UniESI ion source, and configurable M3 emitters to support a wide range of direct infusion applications — native MS, intact protein MS, shotgun lipidomics, and high-throughput workflows that simply weren’t practical before.
Whether we met at the show or you’re learning about UniDirect now, we’d love to walk you through what it can do for your lab. Contact us to schedule a follow-up conversation.
In addition to the UniDirect launch, we are pleased to highlight two recent publications demonstrating the scientific impact of our technologies:
- Trends in Biotechnology – An invited Opinion article discussing next-generation MS front-end technologies and their potential impact on biological and biomedical research.
Read article on cell.com - Analytical Chemistry – A collaborative study led by Genentech with academic and industry partners, demonstrating advanced MS applications for antibody-drug conjugate (ADC) characterization.
Read article on pubs.acs.org
We look forward to continuing discussions with customers, collaborators, distributors, and industry partners worldwide. Pilot systems for UniDirect HT-MS are available in 2026, and we welcome inquiries regarding applications, collaborations, and early-access opportunities.
